Elva Bonifácio Andrade graduated in Biochemistry (University of Porto, UP) in 2005 and obtained her Ph.D. in Biomedical Sciences at the Institute of Biomedical Sciences Abel Salazar (ICBAS-UP), in 2013. Her Ph.D. work focused on the characterization of the innate immune mechanisms leading to neonatal susceptibility to Group B Streptococcus infections. During her postdoctoral studies, she developed a mouse model that recapitulates GBS neonatal infection pathogenesis, with similar features to that described in humans. Since 2020, she has been a Research Scientist at i3S, where she established a new line of research focused on understanding the complex neuro-immune interactions during GBS disease, aiming at developing new therapeutic and neuroprotective strategies. She is also an invited Assistant Professor at ICBAS-UP and at School of Health, Polytechnic Institute of Porto, where she has been enrolled in teaching Immunology and Microbiology.